Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 216
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Does Zika virus replicate in neural cells?

Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

Can We Defeat EBOLA with an Experimental CANCER Drug?

The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims...

Activating brown fat to improve diabetes and obesity

Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

Backer Badge Funded